Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ralph, Q. M.
Right arrow Articles by Morley, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ralph, Q. M.
Right arrow Articles by Morley, A. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: evidence from the Ig heavy chain gene

QM Ralph, MJ Brisco, DE Joshua, R Brown, J Gibson and AA Morley

Department of Haematology, Flinders Medical Centre, Bedford Park, South Australia.

The Ig heavy chain (IgH) gene was used as a marker to investigate clonal succession and the origin of the neoplastic cell in multiple myeloma. The polymerase chain reaction (PCR) was used to amplify a section of the rearranged IgH gene at diagnosis and at progression in 21 patients who had exhibited a plateau phase. A monoclonal PCR product was seen for 16 of the patients and the product present at progression was of the same molecular weight as that at diagnosis. This finding suggests that the IgH rearrangement present at diagnosis and progression was the same. This was confirmed by sequencing the IgH gene in 10 patients. The IgH genes were found to be hypermutated at diagnosis, but no further hypermutation occurred during the course of the disease. The results provide evidence that the neoplastic cell in myeloma may originate as a memory B cell, plasmablast, or plasma cell, and suggest that progression beyond the plateau phase is not caused by clonal succession.

Volume 82, Issue 1, pp. 202-206, 07/01/1993
Copyright © 1993 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
J. A. Burger, P. Ghia, A. Rosenwald, and F. Caligaris-Cappio
The microenvironment in mature B-cell malignancies: a target for new treatment strategies
Blood, October 15, 2009; 114(16): 3367 - 3375.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. J. Taylor, J. Kriangkum, J. A. Pittman, M. J. Mant, T. Reiman, A. R. Belch, and L. M. Pilarski
Analysis of clonotypic switch junctions reveals multiple myeloma originates from a single class switch event with ongoing mutation in the isotype-switched progeny
Blood, September 1, 2008; 112(5): 1894 - 1903.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. J. Taylor, J. A. Pittman, K. Seeberger, M. J. Mant, T. Reiman, A. R. Belch, and L. M. Pilarski
Intraclonal Homogeneity of Clonotypic Immunoglobulin M and Diversity of Nonclinical Post-Switch Isotypes in Multiple Myeloma: Insights into the Evolution of the Myeloma Clone
Clin. Cancer Res., February 1, 2002; 8(2): 502 - 513.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. J. Brisco, P. J. Sykes, G. Dolman, E. Hughes, S.-H. Neoh, L. Peng, L. E. Snell, I. R. G. Toogood, M. S. Rice, and A. A. Morley
Early Resistance to Therapy during Induction in Childhood Acute Lymphoblastic Leukemia
Cancer Res., September 1, 2000; 60(18): 5092 - 5096.
[Abstract] [Full Text]


Home page
BloodHome page
M. Cavo, C. Terragna, G. Martinelli, S. Ronconi, E. Zamagni, P. Tosi, R. M. Lemoli, M. Benni, G. Pagliani, G. Bandini, et al.
Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma
Blood, July 1, 2000; 96(1): 355 - 357.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. S. Sahota, R. Garand, R. Mahroof, A. Smith, N. Juge-Morineau, F. K. Stevenson, and R. Bataille
VH Gene Analysis of IgM-Secreting Myeloma Indicates an Origin From a Memory Cell Undergoing Isotype Switch Events
Blood, August 1, 1999; 94(3): 1070 - 1076.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Perfetti, P. Ubbiali, M. C. Vignarelli, M. Diegoli, R. Fasani, M. Stoppini, A. Lisa, P. Mangione, L. Obici, E. Arbustini, et al.
Evidence That Amyloidogenic Light Chains Undergo Antigen-Driven Selection
Blood, April 15, 1998; 91(8): 2948 - 2954.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. Bataille and J.-L. Harousseau
Multiple Myeloma
N. Engl. J. Med., June 5, 1997; 336(23): 1657 - 1664.
[Full Text] [PDF]


Home page
BloodHome page
S. S. Sahota, R. Leo, T. J. Hamblin, and F. K. Stevenson
Myeloma VL and VH Gene Sequences Reveal a Complementary Imprint of Antigen Selection in Tumor Cells
Blood, January 1, 1997; 89(1): 219 - 226.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1993 by American Society of Hematology         Online ISSN: 1528-0020